PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23696637-10	2013	Incubation with the JAK2 inhibitor, TG101348, abolished the increased phosphorylation of GM-CSFR betac in cells expressing CBL mutants, whereas treatment with the SRC kinase inhibitor dasatinib resulted in equalization of GM-CSFR betac phosphorylation signal between wild type CBL and CBL mutant samples.	Fedratinib	36-44	Cbl proto-oncogene	Homo sapiens	123-126	
23696637-10	2013	Incubation with the JAK2 inhibitor, TG101348, abolished the increased phosphorylation of GM-CSFR betac in cells expressing CBL mutants, whereas treatment with the SRC kinase inhibitor dasatinib resulted in equalization of GM-CSFR betac phosphorylation signal between wild type CBL and CBL mutant samples.	Fedratinib	36-44	Cbl proto-oncogene	Homo sapiens	277-280	
23696637-10	2013	Incubation with the JAK2 inhibitor, TG101348, abolished the increased phosphorylation of GM-CSFR betac in cells expressing CBL mutants, whereas treatment with the SRC kinase inhibitor dasatinib resulted in equalization of GM-CSFR betac phosphorylation signal between wild type CBL and CBL mutant samples.	Fedratinib	36-44	Cbl proto-oncogene	Homo sapiens	277-280